BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 18093358)

  • 41. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
    Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
    Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Periodontitis is characterized by elevated PAI-1 activity.
    Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
    J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis.
    Giddings JC; Morris RJ; Ralis HM; Jennings GM; Davies DA; Woodcock JP
    Clin Lab Haematol; 2004 Aug; 26(4):269-73. PubMed ID: 15279664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
    Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
    Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
    Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
    Rigla M; Mateo J; Fontcuberta J; Souto JC; de Leiva A; Pérez A
    Thromb Haemost; 2000 Aug; 84(2):223-7. PubMed ID: 10959693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW; Pai SH
    Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
    Cerinic MM; Valentini G; Sorano GG; D'Angelo S; Cuomo G; Fenu L; Generini S; Cinotti S; Morfini M; Pignone A; Guiducci S; Del Rosso A; Kalfin R; Das D; Marongiu F
    Semin Arthritis Rheum; 2003 Apr; 32(5):285-95. PubMed ID: 12701039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
    Rask O; Hanséus K; Ljung R; Strandberg K; Berntorp E
    Cardiol Young; 2009 Apr; 19(2):152-8. PubMed ID: 19195416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.